TCWP’s Treace Medical Concepts TMCI Stock Holding History

TCWP’s Portfolio TMCI Stock Details TMCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-215	Closed	-$4K	–	1599
2022 Q1	$4K	Buy	+215	New	+$4.18K	﹤0.01%	1148

Other funds holding TMCI

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

TCWP's TMCI Position: Q2 2022 in Review

TCWP sold out of Treace Medical Concepts (TMCI) in Q2 2022, closing a stake of 215 shares — an estimated $4K sold.

TCWP first reported a position in TMCI in Q1 2022 and held it in 1 quarter. The position peaked at $4K in Q1 2022. 83 funds tracked by Wall St. Rank hold TMCI as of Q2 2022.

TCWP reported no remaining Treace Medical Concepts position as of Q2 2022 after selling out during the quarter.
TCWP sold 215 Treace Medical Concepts shares in Q2 2022, an estimated $4K.
TCWP first reported a position in Treace Medical Concepts in Q1 2022 and held it in 1 quarter.
TCWP's Treace Medical Concepts position peaked at $4K in Q1 2022.
83 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2022.

Based on TCWP's 13F filing for Q2 2022, filed 15 Aug 2022.